Prescription drugs, alternative designs, and the Restatement (Third): preliminary reflections.
This Article is based upon a presentation given at Seton Hall University School of Law's Seventh Annual Health Law Symposium on February 12, 1999.
Green
M D
MD
University of Iowa College of Law, USA.
D003226:Congresses as Topic; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D015195:Drug Design; D006801:Humans; D007880:Legislation, Drug; D008091:Literature; D009515:New Jersey; D004364:Pharmaceutical Preparations; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations